-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Intellia Therapeutics to Peer Perform

Benzinga·11/12/2025 12:00:30
Listen to the news
Wolfe Research analyst Andy Chen downgrades Intellia Therapeutics (NASDAQ:NTLA) from Outperform to Peer Perform.